Denise Morrison said Trump's comments on Tuesday blaming "many sides" for the deadly Charlottesville, Virginia, demonstrations made her reconsider her commitment to the initiative. Johnson & Johnson's CEO Ron Gorsky was also going to leave the panel.
Johnson & Johnson has been hit with a multimillion-dollar jury verdict for the fourth time over whether the talc in its iconic baby powder causes ovarian cancer.
A cheaper version of Johnson & Johnson's top-selling drug, the rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled a key patent on the drug invalid.
Surging second-quarter sales of Johnson & Johnson's prescription drugs, its healthiest business, were more than offset by a one-time gain a year ago, driving profit down 11.5 percent.